Benchmark_logo.jpg
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
28 mai 2020 10h02 HE | The Benchmark Company
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares...
Benchmark_logo.jpg
The Benchmark Company Announces Closing of $8 Million Registered Direct Offering for Cinedigm Corp.
26 mai 2020 18h37 HE | The Benchmark Company
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on May 22nd of a Registered Direct Offering of 10,666,666 shares of common stock of Cinedigm Corp. (NASDAQ:...
Benchmark_logo.jpg
The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc.
17 mars 2020 12h29 HE | The Benchmark Company
NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing on March 16th of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 7,500,000 shares of...
Benchmark_logo.jpg
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
26 févr. 2020 09h00 HE | The Benchmark Company, Llc
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...
Benchmark_logo.jpg
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
13 févr. 2020 15h51 HE | The Benchmark Company, Llc
NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...
Benchmark_logo.jpg
The Benchmark Company Adds Kevin Sterling to Industrial Research Team
12 févr. 2020 13h49 HE | The Benchmark Company, Llc
NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the addition of Kevin Sterling to its rapidly growing equity research team.  Kevin will cover the...
Benchmark_logo.jpg
The Benchmark Company Adds Industrial Research Team to Its Growing Platform
09 janv. 2020 09h00 HE | The Benchmark Company, Llc
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced a significant expansion of its equity research platform, which includes the addition of four senior research...
Benchmark_logo.jpg
Edward Rubin Joins the Benchmark Company as Co-Head of Investment Banking
02 déc. 2019 09h37 HE | The Benchmark Company, Llc
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, a leading investment bank focused on capital markets, equity research and sales & trading for emerging and growth...
Benchmark_logo.jpg
The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc.
13 nov. 2019 16h30 HE | The Benchmark Company, Llc
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the closing of an Initial Public Offering for CNS Pharmaceuticals, Inc. of 2,125,000 shares of common stock at...